60 Years of Scientific Excellence

When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.

Grants & Programs

Conquering cancer — through expanded research, applied knowledge, coordinated partnerships, and community commitment — is the focus of everything we do at the Cancer Research Institute.

CRI’s programs span laboratory research and training, translational investigation, preclinical discovery, and a comprehensive clinical investigation and immunotherapy development strategy. All of these complementary efforts are necessary for CRI to reach its ultimate goal of bringing more FDA-approved immunotherapies to patients with all types of cancer.

As a well-known and respected organization among basic and tumor immunologists, CRI has the ability to convene the world's top scientists to discuss breaking developments or significant challenges in the field at our annual symposia series and colloquia.